Mouse models of childhood cancer of the nervous system.
Targeted cancer treatments rely on understanding signalling cascades, genetic changes, and compensatory programmes activated during tumorigenesis. Increasingly, pathologists are required to interpret molecular profiles of tumour specimens to target new treatments. This is challenging because cancer is a heterogeneous disease-tumours change over time in individual patients and genetic lesions leading from preneoplasia to malignancy can differ substantially between patients. For childhood tumours of the nervous system, the challenge is even greater, because tumours arise from progenitor cells in a developmental context different from that of the adult, and the cells of origin, neural progenitor cells, show considerable temporal and spatial heterogeneity during development. Thus, the underlying mechanisms regulating normal development of the nervous system also need to be understood. Many important advances have come from model mouse genetic systems. This review will describe several mouse models of childhood tumours of the nervous system, emphasising how understanding the normal developmental processes, combined with mouse models of cancer and the molecular pathology of the human diseases, can provide the information needed to treat cancer more effectively.
Dyer
M A
MA
St Jude Children's Research, Department of Developmental Neurobiology, Memphis, TN 38105, USA. michael.dyer@stjude.org
D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D004195:Disease Models, Animal; D006801:Humans; D008527:Medulloblastoma / Q000235:genetics / Q000628:therapy; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D009420:Nervous System / Q000196:embryology; D009423:Nervous System Neoplasms / Q000235:genetics* / Q000628:therapy; D009447:Neuroblastoma / Q000235:genetics / Q000628:therapy; D012175:Retinoblastoma / Q000235:genetics / Q000628:therapy; D014183:Transplantation, Heterologous